Basic Information
ID: ALA841411
Type: Functional
Description: Concentration required to inhibit the PGD-2 evoked cAMP formation in human platelets
Format: BAO_0000019
Organism: Homo sapiens
Target: Prostanoid DP receptor(ALA4427)
Document: ALA1144892
Concentration required to inhibit the PGD-2 evoked cAMP formation in human platelets: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA841411
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 399.53 | 4.68 | 4.68 |
| 383.53 | 4.60 | 4.60 |
| 399.53 | 4.68 | 4.68 |
| 419.57 | 5.82 | 5.82 |
| 413.51 | 4.40 | 4.40 |
| 375.53 | 4.73 | 4.73 |
| 452.64 | 3.72 | 3.72 |
| 376.52 | 4.12 | 4.12 |
| 375.55 | 4.93 | 4.93 |
| 372.51 | 4.01 | 4.01 |
| 385.50 | 4.37 | 4.37 |
| 358.48 | 4.00 | 4.00 |
| 414.50 | 4.58 | 4.58 |
| 389.56 | 5.04 | 5.04 |
| 451.63 | 6.40 | 6.40 |
| 509.67 | 6.63 | 6.63 |
| 481.66 | 5.88 | 5.88 |
| 373.49 | 4.19 | 4.19 |
| 495.64 | 6.12 | 6.12 |
| 518.70 | 5.25 | 5.25 |
| 441.59 | 5.59 | 5.59 |
| 441.59 | 5.59 | 5.59 |
| 375.53 | 4.73 | 4.73 |
| 391.53 | 4.13 | 4.13 |
| 399.56 | 4.01 | 4.01 |
| 369.51 | 4.67 | 4.67 |
| 445.60 | 6.34 | 6.34 |
| 405.56 | 4.74 | 4.74 |
| 389.56 | 5.04 | 5.04 |
| 481.66 | 5.88 | 5.88 |
| 445.60 | 6.34 | 6.34 |
| 481.66 | 5.88 | 5.88 |
| 473.62 | 7.08 | 7.08 |
| 445.60 | 6.34 | 6.34 |
| 408.54 | 5.15 | 5.15 |
| 425.59 | 5.88 | 5.88 |
| 443.58 | 6.02 | 6.02 |
| 409.53 | 5.41 | 5.41 |
| 425.59 | 5.88 | 5.88 |
| 389.56 | 5.07 | 5.07 |
| 425.59 | 5.88 | 5.88 |
| 383.53 | 5.01 | 5.01 |
| 429.63 | 5.61 | 5.61 |
| 465.66 | 6.71 | 6.71 |
| 405.56 | 4.74 | 4.74 |